403 related articles for article (PubMed ID: 23752086)
1. Implementing genomic medicine in pathology.
Williams ES; Hegde M
Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
3. Cancer omics: from regulatory networks to clinical outcomes.
Tang B; Hsu PY; Huang TH; Jin VX
Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing applications in cancer research.
Zhang W; Nykter M; Chen K
Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479
[No Abstract] [Full Text] [Related]
6. Whole-exome/genome sequencing and genomics.
Grody WW; Thompson BH; Hudgins L
Pediatrics; 2013 Dec; 132(Suppl 3):S211-5. PubMed ID: 24298129
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H; Shibata T
Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
[TBL] [Abstract][Full Text] [Related]
9. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
Horswell S; Matthews N; Swanton C
Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
[TBL] [Abstract][Full Text] [Related]
10. Understanding genomic alterations in cancer genomes using an integrative network approach.
Wang E
Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
[TBL] [Abstract][Full Text] [Related]
11. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq.
Feng H; Qin Z; Zhang X
Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057
[TBL] [Abstract][Full Text] [Related]
13. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
Hagemann IS; Cottrell CE; Lockwood CM
Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
[TBL] [Abstract][Full Text] [Related]
14. What can exome sequencing do for you?
Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing for lung cancer.
Wu K; Huang RS; House L; Cho WC
Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing: ready for the clinics?
Desai AN; Jere A
Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumor sequencing on the use of anticancer drugs.
Thomas F; Desmedt C; Aftimos P; Awada A
Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
20. Genomic medicine frontier in human solid tumors: prospects and challenges.
Dienstmann R; Rodon J; Barretina J; Tabernero J
J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
